Our results encompass a range of novel and well-known tumor growth-inhibiting as well as -activating signatures, such as the potential regulation of the ETV4 transcriptional activity by DCN or the PLAU-PLAUR ligand-receptor interaction. The gene discussed is ETV4; the disease is neoplasm.